Oscar Health, Inc.
NYSE:OSCR · New York Stock Exchange
+$0.05 today
Vol 4.82M · Avg 7.51M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+39.08%
Period High
$29.14
Period Low
$10.85
Latest
$28.40
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector

Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.52B

Immunovant, Inc.
NASDAQ:IMVT
$7.26B
Arcellx, Inc.
ACLX
$6.73B

Hinge Health, Inc.
NYSE:HNGE
$5.21B

Alignment Healthcare, Inc.
NASDAQ:ALHC
$4.54B
Akero Therapeutics, Inc.
AKRO
$4.50B

Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.61B

NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
$3.60B

Option Care Health, Inc.
NASDAQ:OPCH
$3.48B

TransMedics Group, Inc.
NASDAQ:TMDX
$2.64B
What is the latest OSCR filing?
The latest filing shown is 8-K dated Jun 9, 2026.
How many recent filings does OSCR have?
Intrinsic Alpha currently shows 20 recent filings for OSCR.
Explore More
Continue the stock analysis
Jump to another research area for this company.